Healthcare Sector
Sector Expertise
Funds advised by Apax Partners invest internationally in companies across a broad range of the healthcare economy, including: clinical stage development of therapeutics, specialty and generic pharmaceuticals, medical products and devices as well as healthcare services.
The companies can either have developed independently, or have been divested from larger companies. The Funds seek to invest in businesses with strong growth potential and outstanding, entrepreneurial management teams capable of building companies of significant value.
Our specialist healthcare team, based across our European and US offices, provides us with a unique ability to support both local and transatlantic opportunities.
News
TriZetto agrees to be acquired by Apax Partners for $22 per share
The TriZetto Group, Inc. announced today that it has entered into a definitive agreement to be acquired and taken private by funds advised by Apax Partners.
Capio announces closing of purchase of Unilabs’ majority shareholders’ stake
Capio today announced that it has closed its purchase of the entire stake of registered and bearer shares and options of Unilabs from its majority shareholders.
Apax Partners Acquires Qualitest Pharmaceuticals and Vintage Pharmaceuticals
Funds advised by Apax Partners have agreed to acquire Qualitest and Vintage Pharmaceuticals, a leading distributor and manufacturer of generic pharmaceuticals based in Huntsville, Alabama, USA.
Sector Insight
The success or failure of large pharmaceutical companies is driven by the so-called blockbuster drugs that have annual sales of at least $1 billion and are used by tens of millions of patients.
However, blockbusters aren’t everything.
Specialty pharmaceuticals, Read More >>